Overview

Sulforadex in Healthy Human Males MAD

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
To determine the safety and tolerability of multiple doses of Sulforadex® in healthy male volunteers over 7 days with qd or bid dosing
Phase:
Phase 1
Details
Lead Sponsor:
Evgen Pharma
Treatments:
Sulforaphane